POC Diagnostics Market Size, Share, Growth, and Industry Analysis, By Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas or Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others), By Application (Clinics, Hospitals, Laboratory, Others), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

POC DIAGNOSTICS MARKET OVERVIEW

The global POC Diagnostics Market size was USD 33.91 billion in 2025 and is projected to reach USD 83.60 billion by 2034, exhibiting a CAGR of 10.4% during the forecast period.

Point-of-Care (POC) Diagnostics is a medical diagnostic test that occurs where the patient receives health care, which can include but is not limited to a doctor visit, hospital bed, or even at home. The paramount objective would be to present fast findings so that quick decision-making of the clinical course and patient management can be made. Hours or days, POC Diagnostics uses small or handheld gadgets and test kits, therefore offering the fast turnaround times characteristic of the traditional, laboratory-based testing. Examples of these are glucose meters in the management of diabetes, rapid strep, and home pregnancy tests. The said technology is important in cases that demand quick diagnosis, e.g., in emergency rooms or chronic conditions monitoring.

The POC Diagnostics Market is a fast-evolving branch of the worldwide diagnostics sector, and its high international use can be explained by the increasing rate of chronic and infectious disorders, the increasing popularity of self-tests and home-based services, and new technologies that have turned the devices more comfortable and accurate. The current POC Diagnostics Market Share is heavily dominated by North America, though the Asia-Pacific region is emerging as the fastest-growing market. The major product segments that are a part of this market are blood glucose monitoring, infectious disease testing (e.g., COVID-19 and influenza), and cardiometabolic monitoring. Healthcare is getting transformed as the growing use of these technologies is decentralizing diagnostics and enhancing patient outcomes.

COVID-19 IMPACT 

The POC Diagnostics Industry Had a Negative Effect Due to Factory Closures During the COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic had a revolutionary effect on the POC Diagnostics Market, elevating the industry to take center stage in the healthcare sphere around the world. This necessitated decentralized testing at scale and pace to control the virus, hence the unprecedented increase in demand for POC testing, in particular in rapid antigen and molecular tests. This emergency has sped up technological advancements, such that the development of user-friendly, at-home test kits was rapidly sped up, and their use was allowed by regulatory bodies. The pandemic itself closed the door over the incorrect perception of diagnostics, sensitizing consumers, medical workers, as well as governments, on their merits of fast and on-site outcomes. The paradigm shift has not only resulted in a phenomenal market growth but also paved the way to the future of diagnostics, putting more emphasis on the enhancement of integration of technologies such as AI and the development of more accessible and consumer-friendly testing in various aspects of infectious diseases and chronic disorders.

LATEST TRENDS

Technological Miniaturization and Connectivity to Drive Market Growth

Miniaturization and connectivity in technologies are a top trend that is transforming the POC Diagnostics Market. This includes the development of smaller, more transportation-friendly devices, such as lab-on-a-chip devices, which minimize sample and reagent volume and thus accelerate and increase the efficiency of tests. Their implementation is becoming more and more focused on easy integrations with smartphones, wearable technology, and electronic health records (EHRs), through Bluetooth or Wi-Fi. Such connectivity allows real-time data transfer and evaluation that can be used to remotely monitor patients, consult by telemedicine, and better manage patients. The net effect of this trend is to increase the area of diagnostics out of hospital-clinical and thus towards the home, empowering the patient and changing the provision of healthcare.

•   
•   
  

  Request a Free sample to learn more about this report

    

POC DIAGNOSTICS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas or Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others.

• Blood Glucose Testing: The increased prevalence of diabetes, the technological improvement of continuous glucose monitoring, and an increasing shift toward home-based and telemedicine-integrated care are making the market more inclined toward it.

• Infectious Diseases Testing: In this segment, there is a flood of demand for multiplex testing platforms that are capable of diagnosing several pathogens simultaneously, a pattern which is largely driven by the COVID-19 pandemic and the necessity of diagnosing respiratory diseases on-site and in a rapid manner.

• Cardiac Markers Testing: The target of innovation is the commercialization of rapid, lab-quality POC cardiac biomarker devices to allow rapid diagnosis and treatment of conditions such as heart attacks in emergency and critical care situations.

• Coagulation Testing: This market is trending towards the use of portable, easy-to-use systems that can be used to monitor blood clotting in real-time, specifically among patients who are under anticoagulation treatment, both in a hospital and at home.

• Pregnancy and Fertility Testing: With an increasing level of awareness and sensitivity to personal reproductive health and with a consequent increase in the number of infertile people, this market has and continues to enjoy new, more sensitive, easier-to-use, and digitally associated at-home tests.

• Blood Gas or Electrolytes Testing: These devices are on the rise in critical care settings, such as ICUs and emergency rooms, where expedience and accuracy of results are crucial to the care of the critically ill patient.

• Tumor Markers Testing: At a still nascent stage of introduction to POC, there is a pattern of developing more convenient and faster tests to detect cancer biomarkers, which would help with early detection or continuous monitoring of any treatments later.

• Urinalysis Testing: Advances in this direction are such new technologies as automated systems and the combination of AI, which increase the efficiency and accuracy of urine research on various disorders, such as urinary tract infection or kidney disease.

• Cholesterol Testing: The increased focus on preventative healthcare is helping the market as well, as there has been an inclination to come up with portable, in-home tests that would give patients immediate information on their lipid profile to assist them in controlling and monitoring cardiovascular conditions.

• Others: The tests in this category are varied, but one characteristic trend is the development of POC systems to treat issues such as sepsis and anemia, often using AI and miniaturized devices to deliver a result within a minute or two using only a drop of blood.

By Application

Based on the Application, the global market can be categorized into Clinics, Hospitals, Laboratory, Others.

• Clinics: POC Diagnostics is the main area of POC Diagnostics Clinics where such devices can be used in modern conditions to carry out rapid on-site tests on many different conditions, allowing not only to increase the level of customer satisfaction but also, on the same day, to make competent decisions regarding further treatment.

• Hospitals: Hospitals use POC Diagnostics as one of their significant end-users, especially the emergency department (ED) and critical care unit (CCU), where the speed of result of blood gases, cardiac markers, and infectious diseases is important to critical life-saving patient treatment and efficient patient handling.

• Laboratories: Although POC testing is not intended to occur in formal labs, central laboratories are critical to the marketplace for quality assurance/control, oversight, and integration of POC results into complete electronic health records/records to facilitate a fully integrated healthcare system.

• Others: The fastest-growing application category consists of home-based care, pharmacies, and assisted-living facilities, as the conveniences of at-home self-testing and the overall decentralization of care grow in popularity.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities, and challenges, stating the market conditions.

Driving Factors

Rising Prevalence of Chronic and Infectious Diseases to Boost the Market

The Rising Prevalence of Chronic and Infectious Diseases is a major factor in the POC Diagnostics Market Growth. Chronic disorders such as diabetes and cardiovascular disorders require frequent check-ups and intervention at early stages, thus POC devices aid in the availability of quick results that are available on the go and in different locations, such as the home of patient. At the same time, the emergence of infectious diseases and, in particular, the experience of the COVID-19 pandemic, has demonstrated the paramount importance of rapid and accurate diagnosis so that a timely response can be quickly implemented in the field of public health and reduce the spread of a potentially dangerous infection. It is this two-pronged pressure (stable management of chronic diseases and emergency quarantine of epidemics) that is driving innovation and the use of sophisticated POC solutions on a global scale.

Technological Advancements and Decentralized Healthcare to Expand the Market

One of the major contributors to the POC Diagnostics Market is technological changes that widen the reach and capabilities of the market. Inventions ranging from miniaturization, biosensors, and metropolitan of artificial intelligence (AI) have resulted in easy-to-carry, precise, and easy-to-use gadgets. The trend towards decentralization of healthcare is directly supported by this progress and shifts the diagnostics away from the centralization in laboratories to the patient. These technologies directly benefit the patient by granting easier access to care, making clinical workflows more efficient, and allowing individuals to play a more active role in the management of their condition, through achieving quick, on-site testing in clinics, pharmacies, or even in the comfort of their homes.

Restraining Factor

Stringent Regulatory and Reimbursement Policies Impede Market Growth

The other such factor where the growth of the POC Diagnostics Market is a huge limitation is the stringent regulatory and reimbursement policies. Delay in the commercialization of innovative products due to the cumbersome and sometimes protracted regulatory clearance procedure, notably in the case of organizations such as the FDA and in Europe, the IVDR, adds to the cost of the product development and the time investment required. Moreover, problems with reimbursement can also cause pricing pressure, which deters the investments and constrains the establishment of new technologies because POC tests can be reimbursed at the same rate as lower value-based tests. The existence of these barriers poses a challenge to companies that would like to exhibit the economic merits of their products and, therefore, expand their market penetration.

AI and Machine Learning Integration for Product Opportunities in the Market

Opportunity

One of the potential ways to grow the market by the inclusion of AI and machine learning in POC Diagnostics is the reinforcement of the main functionalities of such devices through their incorporation. Large amounts of data gathered in one test can be analyzed by AI algorithms, making diagnosis far more accurate and able to detect faint patterns that a human eye would overlook.

Moreover, such smart systems empower predictive analytics, which is the possibility to predict the course of the disease and individual treatment methods. In addition, such smart systems also allow predictive analytics to be used, preparing forecasts of disease progression and individual treatment regimens. Such a combination of innovative technology and handheld devices not only makes diagnostics smarter, but it also creates new possibilities in terms of remote monitoring of patients and active healthcare.

Concerns about Accuracy and Reliability Could Be a Potential Challenge

Challenge

Another threat to the POC Diagnostics Market is the possibility of negative consumer attitudes to the accuracy and reliability of these tests. As compared to a centralized lab, where trained personnel work and high-quality controls are maintained, POC testing tends to use non-laboratory personnel, or the end-user, which means there is a greater risk of user error.

Such factors as improper withdrawal of the sample, problems with its storage, or failure to adhere to the instructions can complicate the results obtained, which again could prompt a consumer to make wrong health decisions. Such insecurity can prove to be a serious obstacle to mass adoption, even with the convenience and expediency that POC devices present.

•   
•   
  Request a Free sample to learn more about this report

    

POC DIAGNOSTICS MARKET: REGIONAL INSIGHTS

• North America

The stance of the global POC Diagnostics Market in North America is dominant, where the key factors influencing it are the strong healthcare infrastructure and Government reimbursement policies. The ability to provide preventive care and patient-centered healthcare models contributes immensely to such growth of the United States POC Diagnostics Market, as there is a high prevalence of chronic diseases, which is another source of the growth. The area is also provided with the leading industry players, and substantial R&D investments related to the development of high-tech solutions such as diagnostics with AI technology.

• Europe

The European POC Diagnostics Market is one of the most promising, where leading growth factors are the increasing prevalence of chronic and infectious diseases and the healthy market demand for decentralized care. Such countries as Germany and the UK are on the front line due to their developed healthcare infrastructure and investment into digital health technologies. The market is also fuelled by the imperative of cutting costs in healthcare, coupled with the rising uptake of quick and on-site tests in clinics and doctors' offices to streamline efficiencies and patient outcomes.

• Asia

Asia Pacific is the fastest growing market of POC Diagnostics, and a compound annual growth rate is highly predicted in the years to come. This is escalated due to the presence of a big and ageing population, rising health awareness, and the developing healthcare infrastructure in freewheeling nations such as China and India. The abundance of infectious and chronic diseases and increasing demand for affordable, accessible diagnostic systems in the urban and rural settings are also driving factors in the region.

KEY INDUSTRY PLAYERS

Key Players Transforming the POC Diagnostics Market Landscape through Innovation and Global Strategy

Through the innovation of strategies and market development, the market players in the field of enterprise are shaping the POC Diagnostics Market. Certain of these can be seen as advancements in designs, Products of materials, and controls, besides the use of smarter technologies for the enhancement of functionality and operational flexibility. Managers are aware of their responsibility to spend money on the development of new products and processes and expand the scope of manufacturing. This market expansion also assists in diversifying the market growth prospects and attaining higher market demand for the product in numerous industries.

List Of Top Poc Diagnostics Companies

• Alere (U.S)
• Roche (Switzerland)
• Abbott Laboratories (U.S.)
• Johnson & Johnson (U.S.)
• Siemens Healthcare (Germany)
• Danaher (U.S.)
• Bayer Healthcare (Germany)
• Beckman Coulter (U.S.)
• Nipro Diagnostics (Japan)
• Bio-Rad Laboratories (U.S.)
• Nova Biomedical (U.S.)
• BioMérieux (France)
• Quidel (U.S.)
• Helena Laboratories (U.S.)
• OraSure Technologies (U.S.)
• Accriva (U.S.)
• Abaxis (U.S.)
• Chembio Diagnostics (U.S.)
• Trinity Biotech (Ireland)

KEY INDUSTRY DEVELOPMENT

March 2023: BioMérieux is positioning itself to bolster its diagnostic capabilities with the use of well-timed acquisitions and alliances in the area of innovative technology. The company developed a collaboration with Oxford Nanopore Technologies and heavily invested in the further development of a molecular sequencing technology in the context of infectious disease diagnostics. In the next year, it bought Lumed, which would add a clinical decision-support software to its digital health offerings. It has further acquired SpinChip Diagnostics and Neoprospecta to showcase an aggressive approach to expand its point-of-care solutions and genomic information services.

REPORT COVERAGE

This report is based on historical analysis and forecast calculations that aim to help readers get a comprehensive understanding of the global POC Diagnostics Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the market's growth by discovering the dynamic categories and potential areas of innovation whose application may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points for consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies, and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.